Gangloff Scott A. — SEC Form 4 filings
SEC reporting owner CIK 1663253. 6 Form 4 filings on record with FilingPulse; latest filed 2025-12-09.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-05-01 to 2025-12-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 848 shares, $46,504 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 848 shares @ $54.84 ($46,504) in Akero Therapeutics, Inc., filed 2025-06-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Akero Therapeutics, Inc. (AKRO) | Chief Technology Officer | 6 | — | 1 leg · 848 sh · $46,504 | 11 |
Form 4 filings — Gangloff Scott A.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-12-09 | 4 | Akero Therapeutics, Inc. (AKRO) | Disposition to issuer (D): 5,088 · Disposition to issuer (D): 21,263 · Disposition to issuer (D): 17,784 (derivative) · Disposition to issuer (D): 73,700 (derivative) · Disposition to issuer (D): 204,616 (derivative) | EDGAR |
| 2025-08-19 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 2,600 @ $19.62 · Option exercise (M): 2,600 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Akero Therapeutics, Inc. (AKRO) | Grant/award (A): 299 @ $23.87 | EDGAR |
| 2025-06-20 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 848 @ $54.84 | EDGAR |
| 2024-12-18 | 4 | Akero Therapeutics, Inc. (AKRO) | Grant/award (A): 24,300 @ $0 · Grant/award (A): 73,700 (derivative) @ $0 | EDGAR |
| 2024-05-01 | 4 | Akero Therapeutics, Inc. (AKRO) | Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1663253 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →